Self-reported hepatitis C virus antibody status and risk behavior in young injectors
Clicks: 379
ID: 115569
1970
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
379 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #4 of 13 articles by views in public health reports (washington, dc : 1974)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Few anti-HCV-positive IDUs in this study were aware of their serostatus. Expanded availability of HCV screening with high quality counseling is clearly needed for this population to promote the health of chronically HCV-infected IDUs and to decrease risk among injectors susceptible to acquiring or t …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (45 words).
Try re-searching for a better abstract.
| Reference Key |
h1970publicself-reported
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hagan H;Campbell J;Thiede H;Strathdee S;Ouellet L;Kapadia F;Hudson S;Garfein RS;; |
| Journal | public health reports (washington, dc : 1974) |
| Year | 1970 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
u.s. gov't
adult
female
male
adolescent
united states / epidemiology
P.H.S.
substance abuse
hepatitis c antibodies / blood
hepatitis c / epidemiology*
health status
intravenous*
risk-taking*
richard s garfein
holly hagan
pmid:17278406
pmc1781913
doi:10.1177/003335490612100611
jennifer campbell
hepacivirus* / pathogenicity
hepatitis c antibodies / isolation & purification*
self disclosure
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.